Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedAdded Type 2 Diabetes as the condition and MedlinePlus Genetics as a related topic on the study page. This strengthens the clinical context and provides an additional reference for readers.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; the page content appears unchanged.SummaryDifference0.1%

- Check29 days agoChange DetectedThe changes remove a government funding notice banner and a few related-topic links (Type 2 diabetes and MedlinePlus Genetics) from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check43 days agoChange DetectedThe page now lists 'Type 2 diabetes' as a condition keyword and adds 'MedlinePlus Genetics' as a related topic; these are minor metadata/content updates that do not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check50 days agoChange DetectedType 2 Diabetes Mellitus as the study condition and the related MedlinePlus Genetics topic have been removed from the page.SummaryDifference0.2%

- Check58 days agoChange DetectedAdded a MedlinePlus Genetics topic: Type 2 diabetes. No deletions present.SummaryDifference0.3%

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.